Citation Impact
Citing Papers
Shortwave infrared fluorescence imaging with the clinically approved near-infrared dye indocyanine green
2018 StandoutNobel
Trial of Psilocybin versus Escitalopram for Depression
2021 Standout
Probing cellular events, one quantum dot at a time
2010
Safety, Tolerability, and Efficacy of Psilocybin in 9 Patients With Obsessive-Compulsive Disorder
2006
Phospholipase C mediates (±)-1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI)-, but not lysergic acid diethylamide (LSD)-elicited head bobs in rabbit medial prefrontal cortex
2012
Upconverting luminescent nanomaterials: application to in vivo bioimaging
2009
Mesoporous silica nanoparticles in biomedical applications
2012 StandoutNobel
Psilocybin-Induced Deficits in Automatic and Controlled Inhibition are Attenuated by Ketanserin in Healthy Human Volunteers
2011
Does phenylethylamine act as an endogenous amphetamine in some patients?
1999
Neurotransmitter, peptide and cytokine processes in relation to depressive disorder: Comorbidity between depression and neurodegenerative disorders
2008
Serotonin, But Not N -Methyltryptamines, Activates the Serotonin 2A Receptor Via a β-Arrestin2/Src/Akt Signaling Complex In Vivo
2010
The Unexpected Influence of Precursor Conversion Rate in the Synthesis of III–V Quantum Dots
2015 StandoutNobel
Rapid translocation of nanoparticles from the lung airspaces to the body
2010 StandoutNobel
Serotonergic and dopaminergic distinctions in the behavioral pharmacology of (±)-1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI) and lysergic acid diethylamide (LSD)
2011
Psychedelics
2016 Standout
The neurobiology of psychedelic drugs: implications for the treatment of mood disorders
2010
Tailor‐Made Ligands for Biocompatible Nanoparticles
2006
Conformational Control of Energy Transfer: A Mechanism for Biocompatible Nanocrystal‐Based Sensors
2012 StandoutNobel
Interaction of 5-HT2A and 5-HT2C Receptors in R(−)-2,5-Dimethoxy-4-iodoamphetamine-Elicited Head Twitch Behavior in Mice
2010
Recent advances in the neuropsychopharmacology of serotonergic hallucinogens
2014
Indigenous Bacteria from the Gut Microbiota Regulate Host Serotonin Biosynthesis
2015 Standout
Serotonergic innervation of the amygdala: targets, receptors, and implications for stress and anxiety
2013
Canine cataplexy is preferentially controlled by adrenergic mechanisms: evidence using monoamine selective uptake inhibitors and release enhancers
1993
The behavioral pharmacology of hallucinogens
2007
Multimodal‐Luminescence Core–Shell Nanocomposites for Targeted Imaging of Tumor Cells
2009
mTOR Signaling in Growth, Metabolism, and Disease
2017 Standout
The role of 5-HT2A, 5-HT2C and mGlu2 receptors in the behavioral effects of tryptamine hallucinogens N,N-dimethyltryptamine and N,N-diisopropyltryptamine in rats and mice
2014
Glutamate neurotoxicity and diseases of the nervous system
1988 Standout
Spatial Charge Configuration Regulates Nanoparticle Transport and Binding Behavior In Vivo
2012 StandoutNobel
Stimulated Release of Size‐Selected Cargos in Succession from Mesoporous Silica Nanoparticles
2012 StandoutNobel
CB1 receptor stimulation in specific brain areas differently modulate anxiety-related behaviour
2007
Deconstructing the photon stream from single nanocrystals: from binning to correlation
2013 StandoutNobel
The Pharmacology of Lysergic Acid Diethylamide: A Review
2008
Increased 5‐HT2A receptors in the temporal cortex of parkinsonian patients with visual hallucinations
2010
Multiple receptors contribute to the behavioral effects of indoleamine hallucinogens
2011
Amplified stimulated emission in upconversion nanoparticles for super-resolution nanoscopy
2017 StandoutNature
Ultrastructural localization of the serotonin transporter in superficial and deep layers of the rat prelimbic prefrontal cortex and its spatial relationship to dopamine terminals
2000
The Neurology of mTOR
2014
Anxiolytic-like effects of DOI microinjections into the hippocampus (but not the amygdala nor the PAG) in the mice four plates test
2007
The Sleep Disorder Canine Narcolepsy Is Caused by a Mutation in the Hypocretin (Orexin) Receptor 2 Gene
1999 Standout
Delivering quantum dots to cells: bioconjugated quantum dots for targeted and nonspecific extracellular and intracellular imaging
2010
Mesoporous silica nanoparticles as nanocarriers
2011
Characterization of the head-twitch response induced by hallucinogens in mice
2013
Synthesis, surface studies, composition and structural characterization of CdSe, core/shell and biologically active nanocrystals
2007
An overview of recent advances in quantum dots for biomedical applications
2014
Hallucinogens Recruit Specific Cortical 5-HT2A Receptor-Mediated Signaling Pathways to Affect Behavior
2007
A Nanoparticle Size Series for In Vivo Fluorescence Imaging
2010 StandoutNobel
AKT/PKB Signaling: Navigating the Network
2017 Standout
The use of fluorescent dyes and probes in surgical oncology
2009
Compact high-quality CdSe–CdS core–shell nanocrystals with narrow emission linewidths and suppressed blinking
2013 StandoutNobel
Pharmacological and behavioral characterization of the 5-HT2A receptor in C57BL/6N mice
2011
Dopaminergic Supersensitivity in G Protein-Coupled Receptor Kinase 6-Deficient Mice
2003 StandoutNobel
Effects of hallucinogenic agents mescaline and phencyclidine on zebrafish behavior and physiology
2012
The substanceou l’histoire mouvementée du LSD
2013
Characterization of behavioral and endocrine effects of LSD on zebrafish
2010
Micelle-Encapsulated Quantum Dot-Porphyrin Assemblies as in Vivo Two-Photon Oxygen Sensors
2015 StandoutNobel
Langmuir Adsorption Study of the Interaction of CdSe/ZnS Quantum Dots with Model Substrates: Influence of Substrate Surface Chemistry and pH
2008
Upconversion Nanoparticles: Design, Nanochemistry, and Applications in Theranostics
2014 Standout
Animal Models of Serotonergic Psychedelics
2012
Atomically Precise Colloidal Metal Nanoclusters and Nanoparticles: Fundamentals and Opportunities
2016 Standout
Silica- and Alkoxysilane-Coated Ultrasmall Superparamagnetic Iron Oxide Particles: A Promising Tool To Label Cells for Magnetic Resonance Imaging
2006
N-Benzyl-5-methoxytryptamines as Potent Serotonin 5-HT2Receptor Family Agonists and Comparison with a Series of Phenethylamine Analogues
2014
Maßgeschneiderte Liganden für biokompatible Nanopartikel
2006
Luminescent Chemodosimeters for Bioimaging
2012 Standout
Stable, small, specific, low-valency quantum dots for single-molecule imaging
2018 StandoutNobel
Repeated lysergic acid diethylamide in an animal model of depression: Normalisation of learning behaviour and hippocampal serotonin 5-HT2 signalling
2014
Supercritical Continuous‐Microflow Synthesis of Narrow Size Distribution Quantum Dots
2008 StandoutNobel
Dynamic changes in prefrontal cortex gene expression following lysergic acid diethylamide administration
2003
Quantum Dot/J-Aggregate Blended Films for Light Harvesting and Energy Transfer
2010 StandoutNobel
Development of a Bioorthogonal and Highly Efficient Conjugation Method for Quantum Dots Using Tetrazine−Norbornene Cycloaddition
2010 StandoutNobel
Marine Indole Alkaloids: Potential New Drug Leads for the Control of Depression and Anxiety
2010 Standout
Magnetic Iron Oxide Nanoparticles: Synthesis, Stabilization, Vectorization, Physicochemical Characterizations, and Biological Applications
2008 Standout
Nonendocytic Delivery of Functional Engineered Nanoparticles into the Cytoplasm of Live Cells Using a Novel, High-Throughput Microfluidic Device
2012 StandoutNobel
A Ligand System for the Flexible Functionalization of Quantum Dots via Click Chemistry
2018 StandoutNobel
Near-Infrared Quantum Dot Emission Enhanced by Stabilized Self-Assembled J-Aggregate Antennas
2017 StandoutNobel
Compact Cysteine-Coated CdSe(ZnCdS) Quantum Dots for in Vivo Applications
2007 StandoutNobel
Compact Biocompatible Quantum Dots via RAFT-Mediated Synthesis of Imidazole-Based Copolymer Ligand
2009 StandoutNobel
Modular poly(ethylene glycol) ligands for biocompatible semiconductor and gold nanocrystals with extended pH and ionic stability
2008
Optical Multiplexed Bioassays for Improved Biomedical Diagnostics
2019
Quantum Shell in a Shell: Engineering Colloidal Nanocrystals for a High-Intensity Excitation Regime
2023 StandoutNobel
Evolution of the Single-Nanocrystal Photoluminescence Linewidth with Size and Shell: Implications for Exciton–Phonon Coupling and the Optimization of Spectral Linewidths
2015 StandoutNobel
In‐Situ Microfluidic Study of Biphasic Nanocrystal Ligand‐Exchange Reactions Using an Oscillatory Flow Reactor
2017 StandoutNobel
Ablation of the mTORC2 component rictor in brain or Purkinje cells affects size and neuron morphology
2013
Minimizing Nonspecific Cellular Binding of Quantum Dots with Hydroxyl-Derivatized Surface Coatings
2008
Variables Influencing Interactions of Untargeted Quantum Dot Nanoparticles with Skin Cells and Identification of Biochemical Modulators
2007
Head‐twitch response in rodents induced by the hallucinogen 2,5‐dimethoxy‐4‐iodoamphetamine: a comprehensive history, a re‐evaluation of mechanisms, and its utility as a model
2012
Facile Epoxidation Strategy for Producing Amphiphilic Up-Converting Rare-Earth Nanophosphors as Biological Labels
2008
Dopamine Axon Varicosities in the Prelimbic Division of the Rat Prefrontal Cortex Exhibit Sparse Immunoreactivity for the Dopamine Transporter
1998
Upconversion Luminescent Materials: Advances and Applications
2014 Standout
Transcriptome Fingerprints Distinguish Hallucinogenic and Nonhallucinogenic 5-Hydroxytryptamine 2A Receptor Agonist Effects in Mouse Somatosensory Cortex
2003
Serotonin Receptors
2008
Reactive Oxygen Species (ROS)-Based Nanomedicine
2019 Standout
Rab3B protein is required for long-term depression of hippocampal inhibitory synapses and for normal reversal learning
2011 StandoutNobel
Synthesis, Characterization, and Bioconjugation of Fluorescent Gold Nanoclusters toward Biological Labeling Applications
2009
Two-Photon Absorbing Nanocrystal Sensors for Ratiometric Detection of Oxygen
2009 StandoutNobel
A Dialogue between the Immune System and Brain, Spoken in the Language of Serotonin
2012
Surface modification and characterization of photon-upconverting nanoparticles for bioanalytical applications
2014
FePt Nanoparticles as an Fe Reservoir for Controlled Fe Release and Tumor Inhibition
2009
Effect of COMT Val 108/158 Met genotype on frontal lobe function and risk for schizophrenia
2001 Standout
Energy Transfer with Semiconductor Quantum Dot Bioconjugates: A Versatile Platform for Biosensing, Energy Harvesting, and Other Developing Applications
2016
Core/Shell Nanoparticles: Classes, Properties, Synthesis Mechanisms, Characterization, and Applications
2011 Standout
DOI-Induced Activation of the Cortex: Dependence on 5-HT2AHeteroceptors on Thalamocortical Glutamatergic Neurons
2000
Quantum Dots for Live Cell and In Vivo Imaging
2009
Magnetic Nanoparticles: Design and Characterization, Toxicity and Biocompatibility, Pharmaceutical and Biomedical Applications
2012 Standout
Optical Multiplexed Bioassays for Improved Biomedical Diagnostics
2019
Surface Modification of Upconverting NaYF4 Nanoparticles with PEG−Phosphate Ligands for NIR (800 nm) Biolabeling within the Biological Window
2009
Efficient Luminescent Down-Shifting Detectors Based on Colloidal Quantum Dots for Dual-Band Detection Applications
2011 StandoutNobel
Quantum dot/antibody conjugates for in vivo cytometric imaging in mice
2015 StandoutNobel
Zwitterionic Biocompatible Quantum Dots for Wide pH Stability and Weak Nonspecific Binding to Cells
2009
Psilocybin-assisted treatment for alcohol dependence: A proof-of-concept study
2015 Standout
Compact Biocompatible Quantum Dots Functionalized for Cellular Imaging
2008 StandoutNobel
Tissue- and Organ-Selective Biodistribution of NIR Fluorescent Quantum Dots
2009 StandoutNobel
Molecular Origin of Blood‐Based Infrared Spectroscopic Fingerprints**
2021 StandoutNobel
Atomically Precise Clusters of Noble Metals: Emerging Link between Atoms and Nanoparticles
2017 Standout
Hallucinogens
2004 Standout
Works of Paul J. Gresch being referenced
REM sleep suppression by monoamine reuptake blockade: Development of tolerance with repeated drug administration
1990
Local Influence of Endogenous Norepinephrine on Extracellular Dopamine in Rat Medial Prefrontal Cortex
1995
Dysregulation of the Norepinephrine Transporter Sustains Cortical Hypodopaminergia and Schizophrenia-Like Behaviors in Neuronal Rictor Null Mice
2010
The serotonin 2C receptor potently modulates the head-twitch response in mice induced by a phenethylamine hallucinogen
2010
Behavioral Tolerance to Lysergic Acid Diethylamide is Associated with Reduced Serotonin-2A Receptor Signaling in Rat Cortex
2005
5-Hydroxytryptamine (Serotonin)2A Receptors in Rat Anterior Cingulate Cortex Mediate the Discriminative Stimulus Properties of d-Lysergic Acid Diethylamide
2006
Stress‐Induced Sensitization of Dopamine and Norepinephrine Efflux in Medial Prefrontal Cortex of the Rat
1994
5-Hydroxytryptamine2C Receptor Contribution to m-Chlorophenylpiperazine and N-Methyl-β-carboline-3-carboxamide-Induced Anxiety-Like Behavior and Limbic Brain Activation
2006
Lysergic acid diethylamide-induced Fos expression in rat brain: role of serotonin-2A receptors
2002
Surface Modification To Reduce Nonspecific Binding of Quantum Dots in Live Cell Assays
2005
Transgenic elimination of high-affinity antidepressant and cocaine sensitivity in the presynaptic serotonin transporter
2011